Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine.
CONCLUSION: This study suggested that workplace productivity gain due to an improvement in symptoms of MDD following treatment with vortioxetine will lead to substantial cost savings for the Canadian economy.
PMID: 31120009 [PubMed - as supplied by publisher]
Source: CNS Spectrums - Category: Neurology Authors: Lachaine J, Beauchemin C, Bibeau J, Patenaude J, Chokka P, Proulx J, Bougie J Tags: CNS Spectr Source Type: research